Jon M Foster Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 weeks, 3 days ago
Jon M Foster has an estimated net worth of at least $58.2 million*, as of Oct. 28, 2026. They own 103,131 shares of HCA stock. They have sold 80,129 shares of HCA stock since 2021, for an estimated $13.9 million.
Jon M Foster $HCA SEC Form 4 Insider Trading
Jon M Foster has filed a total of 13 insider trades in $HCA since 2021. Their most recent trade was a sale of 1,484 shares, made on Nov 06, 2026. Their largest trade was a sale of 16,424 shares, made on Feb 01, 2023. We estimate that they now own 103,131 shares of $HCA, worth an estimated $44.3 million.
Insider Trading at $HCA
There have been a total of 153 insider trades reported at $HCA since 2021, with 95,131 shares purchased and 618,881 shares sold. The most active insider traders in $HCA stock have been Samuel N Hazen, Kathryn A. Torres, and Jon M Foster. The most recent trade was a sale of 3,500 shares reported by Erica Rossitto (SVP & Chief Nurse Executive), made on Nov 10, 2026.
History of Insider Stock Trades by Jon M Foster
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
HCA
|
Sale | 1,484 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 1,684 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 1,066 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 2,692 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 7,595 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 6,302 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 10,000 | Nov 04, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 890 | Nov 06, 2026 | Nov. 6, 2026, 6:09 p.m. |
HCA
|
Sale | 15,698 | May 13, 2025 | May 15, 2025, 5:54 p.m. |
HCA
|
Sale | 16,424 | Feb 01, 2023 | Feb. 1, 2023, 8:57 p.m. |
HCA
|
Sale | 9,000 | Nov 11, 2021 | Nov. 12, 2021, 6:27 p.m. |
HCA
|
Sale | 7,000 | Nov 11, 2021 | Nov. 12, 2021, 6:27 p.m. |
HCA
|
Sale | 294 | Nov 11, 2021 | Nov. 12, 2021, 6:27 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Samuel N Hazen, CEO
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Jon M Foster, EVP and COO
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Charles J Hall, Group President
-
Christopher F. Wyatt, SVP & Controller
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Bill B Rutherford, CFO and EVP
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
Phillip G Billington, SVP-Internal Audit Services
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jeffrey E. Cohen, SVP-Government Relations
-
Michael R Mcalevey, EVP & Chief Legal & Admin Off.
-
Timothy M Mcmanus, Group President
-
Michael J Schlosser, EVP and Chief Clinical Officer
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Erica Rossitto, SVP & Chief Nurse Executive
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.